News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Tennessee
Mergers & acquisitions
Crown Laboratories to Buy Botox Rival Revance Therapeutics for $924M
The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.
August 13, 2024
·
2 min read
·
Tristan Manalac
PRESS RELEASES
Press Releases
Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
October 31, 2024
·
1 min read
Press Releases
Provectus Biopharmaceuticals Announces Investor Webinar for Fourth Quarter 2024 Conference Call
October 25, 2024
·
3 min read
Press Releases
Evergreen Nephrology Appoints John Donlan as CEO
October 23, 2024
·
4 min read
Business
Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details
October 21, 2024
·
1 min read
Press Releases
Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call
October 10, 2024
·
3 min read
Press Releases
Melt Pharmaceuticals Announces Dosing of Last Patient in Pivotal Phase 3 Study of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
October 10, 2024
·
3 min read
Press Releases
DAXOR’S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL ’24
October 9, 2024
·
3 min read
Press Releases
Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 8, 2024
·
2 min read
Press Releases
New CPAP Device with Much Lower Pressure Found as Effective as Traditional CPAP and Reported to be More Comfortable
October 8, 2024
·
5 min read
Press Releases
Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer
October 8, 2024
·
3 min read
Press Releases
Harrow Relaunches TRIESENCE®
October 3, 2024
·
7 min read
Press Releases
Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
September 30, 2024
·
4 min read
Press Releases
Currax Pharmaceuticals Unveils New Disease Awareness Campaign to “Quiet the Food Noise,” a Key Barrier for Individuals Seeking Weight Loss
September 24, 2024
·
2 min read
Press Releases
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
September 19, 2024
·
3 min read
Press Releases
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
September 13, 2024
·
4 min read
Press Releases
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
September 5, 2024
·
3 min read
Business
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 3, 2024
·
3 min read
Press Releases
Navigating Cancer Accelerates Investments to Enhance Care Management Platform for Providers and Patients
September 3, 2024
·
3 min read
News
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study
August 27, 2024
·
3 min read
Press Releases
Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference
August 23, 2024
·
1 min read
